Diadema Partners »

Aytu Biopharma shares owned by Diadema Partners

Quarter-by-quarter ownership of Aytu Biopharma (AYTU) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Aytu Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aytu Biopharma held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aytu Biopharma by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $513k 273k 1.88

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Aytu Biopharma

Nantahala Capital Management
Stonepine Capital Management
AWM Investment Company
Vanguard Group
Diadema Partners
Renaissance Technologies
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
FNY Investment Advisers
Dimensional Fund Advisors
BlackRock
Jaffetilchin Investment Partners
Acadian Asset Management
Tower Research Capital

View all funds holding Aytu Biopharma